(1)
Taegtmeyer, A. B.; Leuppi, J.; Kullak-Ublick, G. Roflumilast – a Phosphodiesterase-4 Inhibitor Licensed for Add-on Therapy in Severe COPD. Swiss Med Wkly 2012, 142, w13628.